FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette FDA Approval: Economics, Not Science? Unpacking the System The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,